Invention Grant
US08835647B2 2-((R)-2-methylpyrrolidin-2-yl)-1H-benzimidazole-4-carboxamide crystalline form 1
有权
2 - （（R）-2-甲基吡咯烷-2-基）-1H-苯并咪唑-4-甲酰胺晶形1
- Patent Title: 2-((R)-2-methylpyrrolidin-2-yl)-1H-benzimidazole-4-carboxamide crystalline form 1
- Patent Title (中): 2 - （（R）-2-甲基吡咯烷-2-基）-1H-苯并咪唑-4-甲酰胺晶形1
-
Application No.: US14039479Application Date: 2013-09-27
-
Publication No.: US08835647B2Publication Date: 2014-09-16
- Inventor: Lawrence Kolaczkowski
- Applicant: AbbVie Inc.
- Applicant Address: US IL North Chicago
- Assignee: AbbVie Inc.
- Current Assignee: AbbVie Inc.
- Current Assignee Address: US IL North Chicago
- Agent Glen J. Gesicki
- Main IPC: C07D235/14
- IPC: C07D235/14
Abstract:
2-((R)-2-Methylpyrrolidin-2-yl)-1H-benzimidazole-4-carboxamide Crystalline Form 1, ways to make it, compositions comprising it and made using it, and methods of treating patients having disease using it are disclosed.
Public/Granted literature
- US20140024838A1 2-((R)-2-METHYLPYRROLIDIN-2-YL)-1H-BENZIMIDAZOLE-4-CARBOXAMIDE CRYSTALLINE FORM 1 Public/Granted day:2014-01-23
Information query
